Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 7 (2024)

Exploring the feasibility and safety of laparoscopic anti-reflux surgery with the new RefluxStopTM device: a retrospective cohort study of 40 patients

DOI
https://doi.org/10.57187/s.3365
Cite this as:
Swiss Med Wkly. 2024;154:3365
Published
15.07.2024

Summary

AIMS OF THE STUDY: Anti-reflux surgery aims to restore the anti-reflux barrier and reduce the retrograde flow of stomach contents. However, traditional surgical techniques generally involve some degree of encircling of the oesophagus, which can result in adverse effects such as dysphagia and the inability to belch or vomit. Based on the first published results, a novel surgical technique – with the RefluxStop™ device – appears promising for treating gastroesophageal reflux disease (GERD) with minimal postoperative dysphagia. This study describes the initial clinical experience with this procedure in a cohort of patients with chronic gastroesophageal reflux disease to evaluate its feasibility and safety in clinical practice.

METHODS: This retrospective cohort study examined the first 40 patients who underwent laparoscopic anti-reflux surgery with the RefluxStop™ device at a private hospital in Switzerland. The procedure involves implanting a nonactive device on the outside of the gastric fundus to stabilise a narrow oesophagogastric plication. Feasibility was assessed based on the proportion of patients in whom the device could be successfully implanted, with a discussion of the operative details. Intraoperative and postoperative complications, adverse effects, and changes in gastroesophageal reflux disease-related quality of life (GERD-HRQL questionnaire) are also reported.

RESULTS: Between May 2020 and April 2022, 40 patients underwent elective surgery for laparoscopic hiatal hernia repair and RefluxStop™ device implantation. All patients had typical symptoms of gastroesophageal reflux disease, such as heartburn and regurgitation; 20 (50%) had preoperative dysphagia. Laparoscopic surgery was feasible in all patients except one who required laparotomy due to adhesions and associated bleeding when accessing the abdomen. The median operating time was 57.5 minutes (interquartile range = 51.75–64.25 minutes) with no device-related intraoperative or postoperative complications. All patients were imaged one day and three months postoperative, confirming the correct placement of the device. Reflux symptoms (heartburn and acid regurgitation) were significantly improved in all patients at three months (p <0.0001).

CONCLUSION: These preliminary results support the feasibility and safety of introducing this novel laparoscopic anti-reflux surgical treatment option in clinical practice.

References

  1. Nirwan JS, Hasan SS, Babar ZU, Conway BR, Ghori MU. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Sci Rep. 2020 Apr;10(1):5814. 10.1038/s41598-020-62795-1 DOI: https://doi.org/10.1038/s41598-020-62795-1
  2. Zhang D, Liu S, Li Z, Wang R. Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study. Ann Med. 2022 Dec;54(1):1372–84. 10.1080/07853890.2022.2074535 DOI: https://doi.org/10.1080/07853890.2022.2074535
  3. Delshad SD, Almario CV, Chey WD, Spiegel BM. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms. Gastroenterology. 2020 Apr;158(5):1250–1261.e2. 10.1053/j.gastro.2019.12.014 DOI: https://doi.org/10.1053/j.gastro.2019.12.014
  4. Slater BJ, Dirks RC, McKinley SK, Ansari MT, Kohn GP, Thosani N, et al. SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD). Surg Endosc. 2021 Sep;35(9):4903–17. 10.1007/s00464-021-08625-5 DOI: https://doi.org/10.1007/s00464-021-08625-5
  5. Savarino V, Marabotto E, Zentilin P, Demarzo MG, de Bortoli N, Savarino E. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Des Devel Ther. 2021 Apr;15:1609–21. 10.2147/dddt.S306371 10.2147/DDDT.S306371 DOI: https://doi.org/10.2147/DDDT.S306371
  6. Greenberg JA, Stefanova DI, Reyes FV, Edelmuth RC, Harik L, Thiesmeyer JW, et al. Evaluation of post-operative dysphagia following anti-reflux surgery. Surg Endosc. 2022 Jul;36(7):5456–66. 10.1007/s00464-021-08888-y DOI: https://doi.org/10.1007/s00464-021-08888-y
  7. Dunn C, Bildzukewicz N, Lipham J. Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am. 2020 Apr;30(2):325–42. 10.1016/j.giec.2019.12.010 DOI: https://doi.org/10.1016/j.giec.2019.12.010
  8. Sheu EG, Nau P, Nath B, Kuo B, Rattner DW. A comparative trial of laparoscopic magnetic sphincter augmentation and Nissen fundoplication. Surg Endosc. 2015 Mar;29(3):505–9. 10.1007/s00464-014-3704-6 DOI: https://doi.org/10.1007/s00464-014-3704-6
  9. Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC. Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 Patients. J Am Coll Surg. 2015 Jul;221(1):123–8. 10.1016/j.jamcollsurg.2015.02.025 DOI: https://doi.org/10.1016/j.jamcollsurg.2015.02.025
  10. Ayazi S, Chowdhury N, Zaidi AH, Chovanec K, Komatsu Y, Omstead AN, et al. Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence. Surg Endosc. 2020 Apr;34(4):1835–46. 10.1007/s00464-019-06950-4 DOI: https://doi.org/10.1007/s00464-019-06950-4
  11. Bjelović M, Harsányi L, Altorjay Á, Kincses Z, Forsell P, Gunjić D, et al.; Investigators of the RefluxStop™ Clinical Investigation Study Group. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark. BMC Surg. 2020 Jul;20(1):159. 10.1186/s12893-020-00794-9 DOI: https://doi.org/10.1186/s12893-020-00794-9
  12. Velanovich V. 25 Years of the GERD-HRQL symptom severity instrument: an assessment of published applications. Surg Endosc. 2023 Jan;37(1):255–65. 10.1007/s00464-022-09463-9 DOI: https://doi.org/10.1007/s00464-022-09463-9
  13. Allen JE, White C, Leonard R, Belafsky PC. Comparison of esophageal screen findings on videofluoroscopy with full esophagram results. Head Neck. 2012 Feb;34(2):264–9. 10.1002/hed.21727 DOI: https://doi.org/10.1002/hed.21727
  14. SS Sami KR. The Los Angeles Classification of Gastroesophageal Reflux Disease. Video Journal and Encyclopedia of GI Endoscopy. 2013;1(1):103-4 DOI:10.1016/S2212-0971(13)70046-3. DOI: https://doi.org/10.1016/S2212-0971(13)70046-3
  15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205–13. 10.1097/01.sla.0000133083.54934.ae DOI: https://doi.org/10.1097/01.sla.0000133083.54934.ae
  16. Richter JE. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol. 2013 May;11(5):465–71. 10.1016/j.cgh.2012.12.006 DOI: https://doi.org/10.1016/j.cgh.2012.12.006
  17. Ayazi S, DeMeester SR, Hagen JA, Zehetner J, Bremner RM, Lipham JC, et al. Clinical Significance of Esophageal Outflow Resistance Imposed by a Nissen Fundoplication. J Am Coll Surg. 2019 Aug;229(2):210–6. 10.1016/j.jamcollsurg.2019.03.024 DOI: https://doi.org/10.1016/j.jamcollsurg.2019.03.024
  18. Schwameis K, Zehetner J, Rona K, Crookes P, Bildzukewicz N, Oh DS, et al. Post-Nissen Dysphagia and Bloating Syndrome: Outcomes After Conversion to Toupet Fundoplication. J Gastrointest Surg. 2017 Mar;21(3):441–5. 10.1007/s11605-016-3320-y DOI: https://doi.org/10.1007/s11605-016-3320-y
  19. Analatos A, Håkanson BS, Ansorge C, Lindblad M, Lundell L, Thorell A. Clinical Outcomes of a Laparoscopic Total vs a 270° Posterior Partial Fundoplication in Chronic Gastroesophageal Reflux Disease: A Randomized Clinical Trial. JAMA Surg. 2022 Jun;157(6):473–80. 10.1001/jamasurg.2022.0805 DOI: https://doi.org/10.1001/jamasurg.2022.0805
  20. Rona KA, Reynolds J, Schwameis K, Zehetner J, Samakar K, Oh P, et al. Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc. 2017 May;31(5):2096–102. 10.1007/s00464-016-5204-3 DOI: https://doi.org/10.1007/s00464-016-5204-3
  21. Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, et al. Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc. 2016 Aug;30(8):3289–96. 10.1007/s00464-015-4659-y DOI: https://doi.org/10.1007/s00464-015-4659-y
  22. Tsai C, Steffen R, Kessler U, Merki H, Lipham J, Zehetner J. Postoperative Dysphagia Following Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease. Surg Laparosc Endosc Percutan Tech. 2020 Aug;30(4):322–6. 10.1097/sle.0000000000000785 10.1097/SLE.0000000000000785 DOI: https://doi.org/10.1097/SLE.0000000000000785
  23. Rona KA, Tatum JM, Zehetner J, Schwameis K, Chow C, Samakar K, et al. Hiatal hernia recurrence following magnetic sphincter augmentation and posterior cruroplasty: intermediate-term outcomes. Surg Endosc. 2018 Jul;32(7):3374–9. 10.1007/s00464-018-6059-6 DOI: https://doi.org/10.1007/s00464-018-6059-6
  24. Baison GN, Jackson AS, Wilshire CL, Bell RC, Lazzari V, Bonavina L, et al. The Impact of Ineffective Esophageal Motility on Patients Undergoing Magnetic Sphincter Augmentation. Ann Surg. 2023 Apr;277(4):e793–800. 10.1097/sla.0000000000005369 10.1097/SLA.0000000000005369 DOI: https://doi.org/10.1097/SLA.0000000000005369
  25. Bonavina L, DeMeester TR, Ganz RA. LINX(™) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):667–74. 10.1586/egh.12.47 DOI: https://doi.org/10.1586/egh.12.47